Implante de Preserflo Microshunt en cámara posterior en un paciente con endotelio comprometido

  1. J.M. Martinez-de-la-Casa 123
  2. F. Saenz-Frances 123
  3. L. Morales Fernandez 123
  4. J. García-Feijoo 123
  1. 1 Universidad Complutense de Madrid
    info

    Universidad Complutense de Madrid

    Madrid, España

    ROR 02p0gd045

  2. 2 Hospital Clínico San Carlos de Madrid
    info

    Hospital Clínico San Carlos de Madrid

    Madrid, España

    ROR https://ror.org/04d0ybj29

  3. 3 Instituto de Investigación Sanitaria del Hospital Clínico San Carlos
    info

    Instituto de Investigación Sanitaria del Hospital Clínico San Carlos

    Madrid, España

    ROR https://ror.org/014v12a39

Show affiliations +
Journal:
Archivos de la Sociedad Española de Oftalmologia

ISSN: 0365-6691

Year of publication: 2022

Volume: 97

Issue: 3

Pages: 161-164

Type: Article

DOI: 10.1016/J.OFTAL.2021.06.003 DIALNET GOOGLE SCHOLAR

More publications in: Archivos de la Sociedad Española de Oftalmologia

Sustainable development goals

Abstract

The objective of the present case is to describe a variation in the Preserflo Microshunt surgical technique, placing it in the posterior chamber to minimise the risk of endothelial cell loss in cases with a compromised endothelium. The patient was a 72-year-old pseudophakic woman, with granular dystrophy and a primary diagnosis of open-angle glaucoma presenting with a progressive visual field defect and an IOP of 26 mmHg with maximal medical therapy. The cornea had incipient stromal folds with an endothelial count of 700 cells/mm2. A Preserflo Microshunt was implanted in the posterior chamber to minimise the possibility of further damage to the corneal endothelium. Six months after surgery, the implant remains functional. The IOP is 9 mmHg without medications. As far as we know, this is the first Preserflo implanted in the posterior chamber described in the literature.

Data source: Dialnet